Phosphorylation of cMet tyrosine residues in murine ascitic hepatic cancer cell lines with different lymph node metastatic potentials

Molecular Medicine Reports

Volumn 8, Issue 2, 2013, Pages 655-661

  Li, Ying ^a   Huang, Xiaohua ^a   Zhang, Qiaoshu ^a   Ma, Keli ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

AKT; Hepatocyte growth factor receptor; Liver cancer; Metastasis; PLC

Indexed keywords

DIACYLGLYCEROL; FIBRONECTIN; LAMININ; LIGAND; PHOSPHOINOSITOL 3 KINASE; PHOSPHOLIPASE C GAMMA; PHOSPHOTRANSFERASE; PROTEIN KINASE B; PROTEIN KINASE C; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASCITIC HEPATIC CANCER CELL LINE; CANCER CELL CULTURE; CELL LINE; CONTROLLED STUDY; IN VITRO STUDY; LIVER CELL CARCINOMA; LYMPH NODE METASTASIS; LYMPH NODE METASTATIC POTENTIAL; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; FIBRONECTINS; HEPATOCYTE GROWTH FACTOR; HUMANS; LIVER NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MICE; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHOLIPASE C GAMMA; PHOSPHORYLATION; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MET; SIGNAL TRANSDUCTION;

MURINAE;

EID: 84879933304     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1527     Document Type: Article

References (18)

1. Edakuni G, Sasatomi E, Satoh T, et al: Expression of the hepatocyte growth factor/c-Met pathway is increased at the cancer front in breast carcinoma. Pathol Int 51: 172-178, 2001.
2. Yamaguchi R, Yano H, Iemura A, et al: Expression of vascular endothelial growth factor in human hepatocellular carcinoma. Hepatology 28: 68-77, 1998.
3. Salgia R: Role of c-Met in cancer: emphasis on lung cancer. Semin Oncol 36 (2 Suppl 1): S52-S58, 2009.
4. Mitra AK: Ligand-independent activation of c-Met by fibronectin and α(5)β(1)-integrin regulates ovarian cancer invasion and metastasis. Oncogene 30: 1566-1576, 2011.
5. Sourbier C: Met and the microenvironment: new insights for ovarian cancer metastasis. Cell Adh Migr 5: 209-210, 2011.
6. Kawakami Y, Kawakami K, Steelant WF, et al: Tetraspanin CD9 is a 'proteolipid,' and its interaction with alpha 3 integrin in microdomain is promoted by GM3 ganglioside, leading to inhibition of laminin-5-dependent cell motility. J Biol Chem 277: 34349-34358, 2002.
7. Sorokin AV, Mikhailov AM, Kachko AV, et al: Human recombinant laminin-binding protein: isolation purification and crystallization. Biochemistry (Mosc) 65: 546-553, 2000.
8. Toledo MS, Suzuki E, Handa K and Hakomori S: Effect of ganglioside and tetraspanins in microdomains on interaction of integrins with fibroblast growth factor receptor. J Biol Chem 280: 16227-16234, 2005.
9. Birchmeier C, Birchmeier W, Gherardi E and Vande Woude GF: Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4: 915-925, 2003.
10. Sun P, Wang XQ, Lopatka K, Bangash S and Paller AS: Ganglioside loss promotes survival primarily by activating integrin-linked kinase/Akt without phosphoinositide 3-OH kinase signaling. J Invest Dermatol 119: 107-117, 2002.
11. Yu H, Fukami K, Itoh T and Takenawa T: Phosphorylation of phospholipase Cgamma1 on tyrosine residue 783 by platelet-derived growth factor regulates reorganization of the cytoskeleton. Exp Cell Res 243: 113-122, 1998.
12. Jeffers M, Rong S and Vande Woude GF: Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis. J Mol Med (Berl) 74: 505-513, 1996.
13. Wang J and Geng X: HGF/cMet signaling pathway in hepatocellular carcinoma invasion and metastasis. J Clin Invest 18: 731-732, 2002.
14. Liu WM and Zhang XA: KAI1/CD82, a tumor metastasis suppressor. Cancer Lett 240: 183-194, 2006.
15. Miyake M, Koyama M, Seno M and Ikeyama S: Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility. J Exp Med 174: 1347-1354, 1991.
16. Todeschini AR, Dos Santos JN, Handa K and Hakomori SI: Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse. J Biol Chem 282: 8123-8133, 2007.
17. Ono M, Handa K, Sonnino S, et al: GM3 ganglioside inhibits CD9-facilitated haptotatic cell motility: coexpression of GM3 and CD9 is essential in the downregulation of tumor cell motility and malignancy. Biochemistry 40: 6414-6421, 2001.
18. Huang X, Li Y, Zhang J, Xu Y, Tian Y and Ma K: Ganglioside GM3 inhibits hepatoma cell motility via down-regulating activity of EGFR and PI3K/AKT signaling pathway. J Cell Biochem 114: 1616-1624, 2013.